Haleon (HLN) Research & Development (2021 - 2025)
Haleon's (HLN) quarterly Research & Development came in at -$205.0 million in Q4 2025, up 23.89% on a QoQ basis from -$269.3 million in Q4 2023.
Haleon (HLN) Research & Development (2021 - 2025) Analysis & Trends
Haleon (HLN) has 4 years of Research & Development data on file, last reported at -$205.0 million in Q4 2025.
- Quarterly Research & Development changed N/A year-over-year to -$205.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$649.9 million (changed N/A YoY) and the FY2025 annual result came in at $420.3 million, up 10.34% from the prior year.
- Research & Development rose to -$205.0 million in Q4 2025, from -$269.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of -$83.8 million in Q2 2023 to a low of -$269.3 million in Q4 2023.
- A 4-year average of -$188.5 million and a median of -$205.0 million in 2025 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development fell 3.65% — and 2023, when it dropped 5.33%.
- Tracing HLN's Research & Development over 4 years: stood at -$246.7 million in 2021, then fell by 3.65% to -$255.7 million in 2022, then fell by 5.33% to -$269.3 million in 2023, then rose by 23.89% to -$205.0 million in 2025.
- The last three Research & Development figures came in at -$205.0 million (Q4 2025), -$269.3 million (Q4 2023), and -$83.8 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.25 Bn | 7.60 Bn | 397.90 Mn | 154.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -204.99 Mn |
| Dec 31, 2023 | -269.33 Mn |
| Jun 30, 2023 | -83.84 Mn |
| May 3, 2023 | -91.71 Mn |
| Dec 31, 2022 | -255.70 Mn |
| Sep 20, 2022 | -167.46 Mn |
| Dec 31, 2021 | -246.69 Mn |